PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjsmedBritish Journal of Sports MedicineVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Br J Sports Med. 1994 June; 28(2): 79–83.
PMCID: PMC1332036

Licit steroid use--hope for the future.

Abstract

Anabolic steroid use has escalated in recent years along with law enforcement. A total of 169 athletes participated in a trial of medical prescription designed to minimize harm as drug elimination is impossible. This showed one-third of athletes achieved their goal in one course, and few were frequent users over the 3-to-5-year period of the trial. Side effects were minimal and reversible.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Csáky TZ. Doping. J Sports Med Phys Fitness. 1972 Jun;12(2):117–123. [PubMed]
  • Corder BW, Dezelsky TL, Toohey JV, Tow PK. An analysis of trends in drug use behavior at five American universities. J Sch Health. 1974 Sep;44(7):386–389. [PubMed]
  • Buckley WE, Yesalis CE, 3rd, Friedl KE, Anderson WA, Streit AL, Wright JE. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 1988 Dec 16;260(23):3441–3445. [PubMed]
  • Perry HM, Wright D, Littlepage BN. Dying to be big: a review of anabolic steroid use. Br J Sports Med. 1992 Dec;26(4):259–261. [PMC free article] [PubMed]
  • Fost N. Banning drugs in sports: a skeptical view. Hastings Cent Rep. 1986 Aug;16(4):5–10. [PubMed]
  • Batey R. The war against drugs. I. Why the war against drugs is not being won. Med J Aust. 1991 Jul 1;155(1):26–28. [PubMed]
  • Perry PJ, Andersen KH, Yates WR. Illicit anabolic steroid use in athletes. A case series analysis. Am J Sports Med. 1990 Jul-Aug;18(4):422–428. [PubMed]
  • Chesher G. Designer drugs--the "whats" and the "whys". Med J Aust. 1990 Aug 6;153(3):157–161. [PubMed]
  • Moore DC, Tattoni DS, Limbeck GA, Ruvelcaba RH, Lindner DS, Gareis FJ, Al-Agba S, Kelley VC. Studies of anabolic steroids: v. effect of prolonged oxandrolone administration on growth in children and adolescents with uncomplicated short stature. Pediatrics. 1976 Sep;58(3):412–422. [PubMed]
  • Pope HG, Jr, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry. 1988 Apr;145(4):487–490. [PubMed]
  • Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. Am J Sports Med. 1984 Nov-Dec;12(6):469–484. [PubMed]
  • Alén M. Androgenic steroid effects on liver and red cells. Br J Sports Med. 1985 Mar;19(1):15–20. [PMC free article] [PubMed]
  • Kuipers H, Wijnen JA, Hartgens F, Willems SM. Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders. Int J Sports Med. 1991 Aug;12(4):413–418. [PubMed]
  • van der Zon P. Safety of testosterone enanthate. Lancet. 1990 Dec 15;336(8729):1517–1518. [PubMed]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group